US › Healthcare

Koninklijke Philips NV ADR (PHG)

US · Healthcare · Medical Devices

$26.47+0.91%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$4.36B
Revenue YoY
+0.5%
Net profit
$384.0M
Profit YoY
+60.0%
EPS
$0.57
EPS estimate
$0.40
Net margin
8.8%

EPS came in at 0.57 against a street estimate of 0.40 — a beat of 42.5%.

Key statistics

Market cap
$25.71B
P/E
20.1
Forward P/E
14.5
P/B
1.96
Book value
$13.51
EPS (TTM)
$1.31
Dividend yield
3.85%
52-week high
$32.19
52-week low
$23.85
50-day MA
$26.64
200-day MA
$27.85
Beta
0.92

Analyst view

Analysts rate Koninklijke Philips NV ADR a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $32.21.

Shareholding

Institutions
5.43%

Largest institutional holders

FundStake
Mondrian Investment Partners Ltd0.80%
Fiduciary Management, Inc. of Milwaukee0.51%
Dimensional Fund Advisors, Inc.0.45%
Morgan Stanley - Brokerage Accounts0.28%
FMR Inc0.28%
Causeway Capital Management LLC0.25%
Northern Trust Corp0.21%
Brandes Investment Partners & Co0.20%

Recent filings & reports

DocumentDate
Proxy statement · Q4 20072007-12-18

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Koninklijke Philips NV ADR — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.